Published AAO appeal decisions

Pharmaceutical researcher claiming EB-1A extraordinary ability asserts evidence of major contributions through highly cited publications on colorectal cancer treatment. AAO held petitioner met only two of three claimed criteria; publications in respected journals do not automatically demonstrate major significance; no evidence of substantial field impact; appeal dismissed.

Bioengineer in precision medicine and drug discovery met first Dhanasar prong with substantial merit and national importance. However, lacked PhD and did not demonstrate sufficient progress, plan, or stakeholder interest required for second prong. Appeal dismissed.

Medical nutrition executive appealed EB-1A denial. AAO found she satisfied three initial evidentiary criteria including high salary, published material, and original contributions. However, appeal dismissed because petitioner failed final merits determination; evidence insufficient to establish sustained national or international acclaim placing her among the small percentage at the field's very top.

A biomedical scientist and biotechnology executive with experience in molecular biology and clinical diagnostics proposed to establish a venture consulting practice for early-stage biotech companies. The AAO dismissed the appeal because the petitioner failed to demonstrate the proposed endeavor's national importance; the record showed only individualized client services without broader field-wide impact.

Chemical and biomedical engineer with Ph.D. sought EB-2 classification and NIW. Petitioner established first prong of substantial merit and national importance of proposed research endeavor. AAO agreed but found petitioner did not sufficiently demonstrate record of success in related efforts, citations impact, or viable plan with documentary support for claimed employment.

Chemical engineer with five years pharmaceutical and biotechnology experience sought EB-2 with national interest waiver. Proposed developing analytical methods and processes for vaccine and therapeutic manufacturing. AAO dismissed because petitioner failed to demonstrate proposed work has national importance; work appeared routine to employer without broader industry impact.

Research and development manager in personal care industry sought EB-1A. Met leading or critical role criterion but failed membership, original contributions, and scholarly articles criteria. AAO declined final merits analysis due to insufficient threshold evidence.

An employer sought a national interest waiver for a beneficiary as associate vice president in pharmaceutical supply chain management. The AAO held the proposed endeavor lacked demonstrated national importance under Dhanasar's first prong because work would not impact the field broadly, merely addressing company-specific needs despite being in an important sector.

A nicotine manufacturer petitioned for a director of product development under EB-2 advanced degree and Schedule A Group II. The beneficiary met two of seven evidentiary criteria (judging and scholarly articles). The AAO affirmed denial because the record did not demonstrate widespread acclaim and international recognition required for Schedule A designation.

CEO and inhaled drug delivery researcher claimed EB-1A extraordinary ability, satisfying five initial evidentiary criteria. AAO held totality of evidence insufficient for final merits determination; petitioner lacked sustained national acclaim and did not demonstrate career of acclaimed work placing him among field's very top.

A senior scientist with doctoral degree in biology at a multinational pharmaceutical company sought NIW for EB-2. The AAO dismissed appeal after finding proposed drug design research endeavor lacks national importance. Published work and connection to broad health initiatives insufficient; specific endeavor impact not demonstrated at national scale.

An employer petitioned for NIW for study management associate II overseeing oncology and hematology clinical trials for advanced therapies. AAO affirmed denial: while the work was meritorious, petitioner failed to show the specific endeavor had national importance or substantial economic impact beyond the employer's clients and consumers.

Biotechnology researcher proposes developing genomic editing tools for disease modeling and gene therapy targeting neurodegenerative and autoimmune disorders. AAO found the endeavor has substantial merit but rejected it because the record fails to establish the proposed endeavor's prospective impact or national importance, relying instead on general industry importance.

Postdoctoral researcher with advanced degrees seeks NIW for CAR T cell research involving epigenetic reprogramming. AAO found endeavor meets national importance but failed to demonstrate she is well positioned to advance it despite citations and peer review participation.

Postdoctoral research scientist in pharmaceutical sciences claimed three evidentiary criteria, all met at initial stage. AAO upheld dismissal because evidence of peer review, citations, and articles did not establish sustained national or international acclaim or placement among the very top of the field as required.

Formulation scientist with Ph.D. seeks NIW for drug delivery systems research. AAO found substantial merit and national importance of proposed research endeavor but concluded petitioner failed to demonstrate independence from employer, failing second prong.

Postdoctoral bioelectronics researcher sought EB-1A classification. AAO dismissed motion to reconsider prior appeal dismissal, affirming that record failed to establish major significance of contributions and did not meet the minimum three criteria threshold.

Pharmaceutical research scientist sought EB-1A classification claiming three criteria. AAO dismissed appeal, finding only judging and scholarly articles met but original contributions lacked evidence of major significance and sustained national or international acclaim.

A graduate student in biomedical engineering seeks NIW for research on photoacoustic imaging in clinical settings. The AAO found the endeavor has substantial merit and national importance but dismissed because the petitioner did not demonstrate she is well-positioned to advance it, lacking a Ph.D., documented employment, or evidence of progress or investor interest.

Clinical pharmacologist employed by biopharmaceutical company met three initial evidentiary criteria but lacked sustained national or international acclaim demonstrating placement among the very top of field in pharmacokinetics and pharmacodynamics; appeal dismissed on final merits.

Biomechanical engineer and researcher claiming NIW for EB-2 with proposed endeavor in cell therapy and biomaterials. Substantial merit found but national importance not established; prospective impact not attributed to petitioner or shown to have prospective economic effect. Appeal dismissed.

Doctoral candidate in medical research seeking EB-2 NIW for developing medical devices for organ preservation and hypoxia treatment. AAO found first prong met but dismissed, finding petitioner not well-positioned to advance endeavor due to lack of Ph.D. at filing and insufficient connection of prior research to proposed medical device work.